Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase II, Open-label, Parallel 2-arm, Multi-center”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Testing effectiveness (Phase 2)Ended earlyNCT00104338
What this trial is testing

Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

Who this might be right for
BK PolyomavirusKidney Diseases
Astellas Pharma Inc 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05026905
What this trial is testing

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Who this might be right for
Phase II, Open-label, Parallel 2-arm, Multi-center
National Health Research Institutes, Taiwan 66
Post-approval studies (Phase 4)Study completedNCT03147677
What this trial is testing

Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

Who this might be right for
Type 2 Diabetic Nephropathy
The Third Xiangya Hospital of Central South University 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation